Summary Ozempic stands out as a reliable and effective medication for managing diabetes and aiding weight loss, primarily due to its FDA approval, standardized dosing, and proven results in clinical studies
Your prescriber may need to change your dose or stop treatment
Further, the hospital distribution channels offer continuity of care among patients who started the GLP-1 therapy in hospitals to manage diabetes complications, cardiovascular events, or bariatric surgery to provide proper follow-up and adherence to medication during these high-risk transition periods
10.2174/1871527319666200303121016 [DOI] [PubMed] [Google Scholar] Kida S., Serita T
Eli Lilly is studying the pill in a longer study in people who are overweight or have obesity to see if the weight loss continues
Q: What is the role of the DSRIP Independent Evaluator